News Pain Therapeutics' opioid drug fails to gain FDA approval The US regulator has rejected Pain Therapeutics' abuse-deterrent opioid painkiller drug, Remoxy, for the fourth time.
News FDA encourages cheap abuse-deterrent painkillers Regulator waiting for non-opioid alternatives to reach the market
News US opioid crisis a 'national emergency', says Trump Declaration means potential more resources and power to states and federal agencies.
News Endo gives way and withdraws opioid painkiller after FDA pre... Pharma makes decision after FDA intervenes to fight opioid crisis.
News FDA fast-tracks Lilly/Pfizer pain drug amid opioid crisis Companies hope tanezumab offers alternative to opioids
News FDA makes unprecedented move, asks Endo to pull painkiller f... Regulator concerned about potential abuse of Opana ER
R&D Proving ROI for digital endpoints The costs associated with clinical trials are a major bottleneck to drug development and affordability.
Digital Fixing clinical trial data management It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.